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Introduction
Hypoxia has been shown to exert immunomodulatory
effects1. As oxygenation is daily practice in critical care,
and the majority of critically ill patients suffer from
inflammatory-related conditions, permissive hypoxia
might be a novel therapeutic strategy. In addition, there
are pharmacologic hypoxia-mimetics available that can
replicate the hypoxia-effects without the potential draw-
backs of systemic hypoxia. The hypoxic immunomodu-
latory effects are thought to be mediated through a
group of transcription factors called hypoxia-inducible
factors (HIFs)2. However, in vitro studies have demon-
strated that, depending on the cell-type, these effects
can be both pro- and anti-inflammatory. The net effects
of hypoxia during systemic inflammation in vivo are
therefore unknown.
Objectives
To determine the immunomodulatory effects of various
degrees of hypoxia and hypoxia mimetics during systemic
inflammation in mice.
Methods
BALB/c mice (n = 8 per group) were placed in an air-tight
cage with variable degrees of oxygen (normal (21%), 12%,
9%, and 6%), or were injected with the hypoxia-mimetic
cobalt chloride (CoCl2, 30mg/kg i.p.). After 1 hour, LPS (5
mg/kg E. Coli endotoxin, serotype 0111:B4) or placebo
(NaCl 0.9%) was administered i.p. Ninety minutes after
LPS/placebo administration, rectal temperature was
measured and animals were sacrificed. Blood plasma was
analyzed for cytokine concentrations. Furthermore,
mRNA expression of interleukin (IL)-10 and the HIF-1a
target gene vascular endothelial growth factor (VEGF)
were determined in spleen samples.
Results
As expected, LPS administration resulted in hypothermia.
Hypoxia and CoCl2 also lowered body temperature, in a
dose-dependent fashion (Figure 1). Hypoxia itself did not
result in elevated cytokine levels in plasma. Endotoxemia
resulted in increased levels of circulating pro-inflammatory
cytokines Tumor Necrosis Factor (TNF)-a, IL-6, IL-8, as
well as anti-inflammatory IL-10 (Figure 2). Hypoxia
and CoCl2 attenuated the endotoxin-induced pro-
inflammatory cytokine response in a dose-dependent
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Figure 1 Rectal temperature in degrees Celsius (°C). Data are
shown as mean ± SEM. Stastistical analysis was performed
using two-way analysis of variance with Bonferonni post-hoc
tests. * p < 0.05 compared with normoxia (21% with same
LPS/placebo) # p < 0.05 compared with placebo (same %
oxygen or CoCl2).
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manner, while IL-10 protein levels were relatively
unaffected. Furthermore, hypoxia resulted in a dose-
dependent upregulation of splenic VEGF and IL-10
mRNA expression (Figure 3).
Conclusions
Hypoxia results in hypothermia and attenuation of the sys-
temic pro-inflammatory response in a dose-dependent
fashion, while preserving or enhancing the anti-inflamma-
tory response. Administration of the hypoxia-mimetic
CoCl2 results in a similar immunological phenotype. Our
results suggest that permissive hypoxia is a novel non-
pharmacological anti-inflammatory therapeutic strategy.
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Figure 2 Plasma cytokines (Tumor Necrosis Factor (TNF)a, Interleukin(IL)-6, IL-8 and IL-10). Data are shown as mean ± SEM. Statistical
analysis was performed using two-way analysis of variance with Bonferonni post-hoc tests. * p < 0.05 compared with normoxia (21%
with same LPS/placebo). # p < 0.05 compared with placebo (same % oxygen of CoCl2)
Figure 3 Splenic mRNA expression of Interleukin 10 (IL-10) and vascular endothelial growth factor (VEGF). Data are shown as mean ±
SEM. Statistical analysis was performed using two-way analysis of variance with Bonferonni post-hoc tests. * p < 0.05 compared with
normoxia (21% with same LPS/placebo). # p < 0.05 compared with placebo (same % oxygen of CoCl2)
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